www.telegraph.co.uk/health/healthnews/10221767/Dr-Andrew-Lawson-If-Id-relied-solely-on-the-NHS-to-treat-me-I-might-well-be-dead.html
The article is a bit of a rant, but this is the relevant paragraph:
"I know something about this – as a former NHS consultant, and more recently as a patient. In 2007, at the age of 48, I was diagnosed with a malignant pleural mesothelioma, a form of lung cancer caused by exposure to asbestos. It seems that, while at medical school, I was exposed to asbestos fibres in some part of the hospital (four other doctors and dentists from my era developed the disease; I am the only one surviving). As a result, I have experienced care in the NHS and in the private sector as well as taking part in a trial in the US.
I’m still alive six years on, the average time before death being 12-14 months, but there is nothing I received that couldn’t be offered to any NHS patient if only the system were more flexible. Unfortunately, it isn’t. It does not routinely move patients from unit to unit, it does not routinely tell cancer patients of trials taking place here and overseas, and it discourages accessing other opinions.
I was fortunate because I had insured myself years ago, long before my diagnosis, after being told that private patients had access to some anti-cancer drugs that NHS patients did not. So I was able to use my insurance to be operated on by a surgeon I chose. It was also my decision to go to the US to take part in a trial, but access to the trial was available to anyone if only they had been told about it. The $20,000 trial drugs were free. This, of course, was easy for me – I knew where to look and who to ask. It was clear to me that most NHS patients were simply not told about such trials.
I was also given a drug, at my request because I’d researched it, which may well have delayed my tumour’s growth. Bisphosphonate is used extensively for other reasons, is readily available and not expensive, yet I know of patients who have asked for it on the NHS to treat their mesothelioma, but been refused on the grounds of lack of evidence. Others have been given it when they asked. There is early evidence that it can be effective, and everyone who works in the field knows about this, but it’s not yet officially approved by the National Institute for Health and Care Excellence (Nice)."